/Investor DB

Tuatara Capital — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Hound LabsinSep 2021 · $20M

Workplace drug-testing company combining a short-window cannabis breath test, customizable oral-fluid/urine panels, a cloud results record and integrated background screening.

Medical DevicesRichmond, US

Michael Lynn(Executive Officer, Director)Michael 'Mike' Lynn, MD(Co-founder; former CEO and board chair)Jenny Lynn(Co-founder; former Chief Marketing Officer)Kuni Oh(Co-founder; technical/scientific founder)Sam Kabbani(Chief Executive Officer)Kathy Henderson(Chief Operating Officer / Chief Financial Officer)in

Co-investorsHorizon Technology FinanceBenchmarkIcon Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.